Calypte Biomedical Corp. Quarterly Income Statement Display Annual Data
More filings for Calypte Biomedical Corp. available from EDGAR Online. Get a Free Trial to EDGAR Online Premium
Income Statement Balance Sheet Cash Flow Statement
Period Ending: Dec 31, 2002 Sep 30, 2002 Jun 30, 2002 Mar 31, 2002
Total Revenue $809,000 $493,000 $1,209,000 $1,159,000
Cost Of Revenue $1,593,000 $1,542,000 $1,397,000 $1,630,000
Gross Profit ($784,000) ($1,049,000) ($188,000) ($471,000)
Operating Expenses
Research And Development $289,000 $219,000 $180,000 $241,000
Selling General And Administrative Expenses $4,139,000 $1,565,000 $2,087,000 $1,215,000
Non Recurring N/A N/A N/A N/A
Other Operating Expenses N/A N/A N/A N/A
Operating Income ($5,212,000) ($2,833,000) ($2,455,000) ($1,927,000)
Total Other Income And Expenses Net ($17,000) $12,000 $15,000 $9,000
Earnings Before Interest And Taxes ($5,229,000) ($2,821,000) ($2,440,000) ($1,918,000)
Interest Expense $993,000 ($1,326,000) $2,492,000 $47,000
Income Before Tax ($6,222,000) ($1,495,000) ($4,932,000) ($1,965,000)
Income Tax Expense N/A N/A N/A $2,000
Equity Earnings Or Loss Unconsolidated Subsidiary N/A N/A N/A N/A
Minority Interest N/A N/A N/A N/A
Net Income From Continuing Operations ($6,222,000) ($1,495,000) ($4,932,000) ($1,967,000)
Nonrecurring Events
Discontinued Operations N/A N/A N/A N/A
Extraordinary Items N/A N/A N/A $1,319,000
Effect Of Accounting Changes N/A N/A N/A N/A
Other Items N/A N/A N/A N/A
Net Income ($6,222,000) ($1,495,000) ($4,932,000) ($648,000)
Preferred Stock And Other Adjustments ($30,000) ($30,000) ($30,000) ($30,000)
Net Income Applicable To Common Shares ($6,252,000) ($1,525,000) ($4,962,000) ($678,000)
More filings for Calypte Biomedical Corp. available from EDGAR Online. Get a Free Trial to EDGAR Online Premium
EDGAR Online: Research People in this company | Full text Search
ADVERTISEMENT
|
Thread abonnieren
ETF-Sparplan